Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Achieve Life Sciences (ACHV) Deferred Taxes (2016 - 2017)

Achieve Life Sciences (ACHV) has disclosed Deferred Taxes for 3 consecutive years, with -$2.9 million as the latest value for Q3 2017.

  • Quarterly Deferred Taxes fell 2036.5% to -$2.9 million in Q3 2017 from the year-ago period, while the trailing twelve-month figure was -$3.2 million through Dec 2017, down 530.56% year-over-year, with the annual reading at -$3.1 million for FY2017, 505.36% down from the prior year.
  • Deferred Taxes for Q3 2017 was -$2.9 million at Achieve Life Sciences, down from -$124000.0 in the prior quarter.
  • The five-year high for Deferred Taxes was -$118000.0 in Q1 2016, with the low at -$2.9 million in Q3 2017.
  • Average Deferred Taxes over 3 years is -$566000.0, with a median of -$127000.0 recorded in 2016.
  • The sharpest move saw Deferred Taxes skyrocketed 68.8% in 2016, then plummeted 2036.5% in 2017.
  • Achieve Life Sciences' Deferred Taxes stood at -$407000.0 in 2015, then skyrocketed by 68.8% to -$127000.0 in 2016, then plummeted by 2204.72% to -$2.9 million in 2017.
  • Per Business Quant, the three most recent readings for ACHV's Deferred Taxes are -$2.9 million (Q3 2017), -$124000.0 (Q1 2017), and -$127000.0 (Q4 2016).